Several studies have demonstrated that metabolic disorders, such as obesity, insulin resistance, and impaired glucose metabolism, can contribute to the activation of the NLRP3 inflammasome and subsequent neuroinflammation. The gene discussed is NLRP3; the disease is obesity disorder.